Big data and benchmarking initiatives to bridge the gap from AlphaFold to drug design

Nat Chem Biol. 2024 Mar 8. doi: 10.1038/s41589-024-01570-z. Online ahead of print.

Matthieu Schapira^{1

2}, Levon Halabelian^{1

2}, Cheryl H Arrowsmith^{1

3

4}, Rachel J Harding^{5

6}

¹ Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
² Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
³ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
⁴ Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁵ Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. rachel.harding@utoronto.ca.
⁶ Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. rachel.harding@utoronto.ca.

No abstract available